Our findings strongly indicated that α-mangostin functioned as a sensitizer of TRAIL-induced apoptosis and could become a possible adjuvant compound for cytokine therapy to conquer TRAIL-resistance in TRAIL-resistant cancer cells and in cancer-stem cells. Here, TNFSF10 is linked to cancer.